INS and metabolic dysfunction-associated steatotic liver disease: Several KEGG pathways were identified (p < 0.05): signaling pathway; PPAR signaling pathway; nonalcoholic fatty liver disease (NAFLD); insulin resistance; insulin signaling pathway; regulation of lipolysis in adipocytes; adipocytokine signaling pathway; fatty acid biosynthesis; pathways in cancer; and transcriptional mis-regulation in cancer.